Sanofi SA
XHAM:SNW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sanofi SA
XHAM:SNW
|
FR |
|
S
|
Stanley Black & Decker Inc
XBER:SWF
|
US |
|
Reckitt Benckiser Group PLC
OTC:RBGPD
|
UK |
|
E
|
Exor NV
OTC:EXXRF
|
NL |
|
C
|
Capita PLC
XBER:CTAA
|
UK |
|
S
|
SPS Commerce Inc
SWB:S86
|
US |
|
C
|
CITIC Securities Co Ltd
XBER:CI9
|
CN |
|
A
|
Alamos Gold Inc
NYSE:AGI
|
CA |
|
ACS Actividades de Construccion y Servicios SA
F:OCI
|
ES |
Wall St Price Targets
SNW Price Targets Summary
Sanofi SA
According to Wall Street analysts, the average 1-year price target for SNW is 97.82 EUR with a low forecast of 57.58 EUR and a high forecast of 117.63 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SNW's stock price target?
Price Target
97.82
EUR
According to Wall Street analysts, the average 1-year price target for SNW is 97.82 EUR with a low forecast of 57.58 EUR and a high forecast of 117.63 EUR.
What is the Revenue forecast for Sanofi SA?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 0%.
What is the Operating Income forecast for Sanofi SA?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 2%.
What is the Net Income forecast for Sanofi SA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 5%.
